98 related articles for article (PubMed ID: 21511279)
21. RUNX3 inhibits hypoxia-inducible factor-1α protein stability by interacting with prolyl hydroxylases in gastric cancer cells.
Lee SH; Bae SC; Kim KW; Lee YM
Oncogene; 2014 Mar; 33(11):1458-67. PubMed ID: 23542169
[TBL] [Abstract][Full Text] [Related]
22. Anticancer Effects of Zinc Oxide Nanoparticles Through Altering the Methylation Status of Histone on Bladder Cancer Cells.
Zhang T; Du E; Liu Y; Cheng J; Zhang Z; Xu Y; Qi S; Chen Y
Int J Nanomedicine; 2020; 15():1457-1468. PubMed ID: 32184598
[TBL] [Abstract][Full Text] [Related]
23. Discovery of Orally Available Runt-Related Transcription Factor 3 (RUNX3) Modulators for Anticancer Chemotherapy by Epigenetic Activation and Protein Stabilization.
Yang JS; Lee C; Cho M; Kim H; Kim JH; Choi S; Oh SJ; Kang JS; Jeong JH; Kim HJ; Han G
J Med Chem; 2015 Apr; 58(8):3512-21. PubMed ID: 25811792
[TBL] [Abstract][Full Text] [Related]
24. Identification of gene expression signature modulated by nicotinamide in a mouse bladder cancer model.
Kim SK; Yun SJ; Kim J; Lee OJ; Bae SC; Kim WJ
PLoS One; 2011; 6(10):e26131. PubMed ID: 22028816
[TBL] [Abstract][Full Text] [Related]
25. Cyclin D1 blocks the anti-proliferative function of RUNX3 by interfering with RUNX3-p300 interaction.
Iwatani K; Fujimoto T; Ito T
Biochem Biophys Res Commun; 2010 Sep; 400(3):426-31. PubMed ID: 20801098
[TBL] [Abstract][Full Text] [Related]
26. Histone deacetylase inhibitors upregulate plakoglobin expression in bladder carcinoma cells and display antineoplastic activity in vitro and in vivo.
Canes D; Chiang GJ; Billmeyer BR; Austin CA; Kosakowski M; Rieger-Christ KM; Libertino JA; Summerhayes IC
Int J Cancer; 2005 Feb; 113(5):841-8. PubMed ID: 15499627
[TBL] [Abstract][Full Text] [Related]
27. Anti-tumor effects of resveratrol on malignant melanoma is associated with promoter demethylation of RUNX3 gene.
Kang S; Wang Z; Li B; Gao X; He W; Cao S; Cai Y; Chen H
Pharmazie; 2019 Mar; 74(3):163-167. PubMed ID: 30961683
[TBL] [Abstract][Full Text] [Related]
28. RUNX3 is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancer.
Lau QC; Raja E; Salto-Tellez M; Liu Q; Ito K; Inoue M; Putti TC; Loh M; Ko TK; Huang C; Bhalla KN; Zhu T; Ito Y; Sukumar S
Cancer Res; 2006 Jul; 66(13):6512-20. PubMed ID: 16818622
[TBL] [Abstract][Full Text] [Related]
29. Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines.
Jiang Y; Tong D; Lou G; Zhang Y; Geng J
Pathobiology; 2008; 75(4):244-51. PubMed ID: 18580070
[TBL] [Abstract][Full Text] [Related]
30. Detection of deleted in malignant brain tumors 1 and runt-related transcription factor 3 gene expressions in bladder carcinoma.
Dodurga Y; Avcı CB; Satiroglu-Tufan NL; Tataroglu C; Kesen Z; Doğan ZO; Yılmaz S; Gündüz C
Mol Biol Rep; 2012 Apr; 39(4):4691-5. PubMed ID: 21956756
[TBL] [Abstract][Full Text] [Related]
31. Effect of histone deacetylase inhibitors on cell apoptosis and expression of the tumor suppressor genes RUNX3 and ARHI in ovarian tumors.
Zhang L; Liu P; Li H; Xue F
Mol Med Rep; 2013 May; 7(5):1705-9. PubMed ID: 23504001
[TBL] [Abstract][Full Text] [Related]
32. RUNX3 inhibits the expression of vascular endothelial growth factor and reduces the angiogenesis, growth, and metastasis of human gastric cancer.
Peng Z; Wei D; Wang L; Tang H; Zhang J; Le X; Jia Z; Li Q; Xie K
Clin Cancer Res; 2006 Nov; 12(21):6386-94. PubMed ID: 17085650
[TBL] [Abstract][Full Text] [Related]
33. Effects of 5-azacytidine on RUNX3 gene expression and the biological behavior of esophageal carcinoma cells.
Wang S; Liu H; Wang Z; Chen HX
Mol Med Rep; 2014 Apr; 9(4):1259-65. PubMed ID: 24535051
[TBL] [Abstract][Full Text] [Related]
34. Promoter hypermethylation of the RUNX3 gene in esophageal squamous cell carcinoma.
Long C; Yin B; Lu Q; Zhou X; Hu J; Yang Y; Yu F; Yuan Y
Cancer Invest; 2007 Dec; 25(8):685-90. PubMed ID: 18058463
[TBL] [Abstract][Full Text] [Related]
35. RUNX3 is multifunctional in carcinogenesis of multiple solid tumors.
Chuang LS; Ito Y
Oncogene; 2010 May; 29(18):2605-15. PubMed ID: 20348954
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of the growth and metastasis of human colon cancer by restoration of RUNX3 expression in cancer cells.
Peng Z; Tang H; Wang X; Zhou C; Fan J; Wang L; Jia Z; Li Q; Le X; Wei D; Xie K
Int J Oncol; 2008 Nov; 33(5):979-84. PubMed ID: 18949360
[TBL] [Abstract][Full Text] [Related]
37. Compound K, a metabolite of ginseng saponin, inhibits colorectal cancer cell growth and induces apoptosis through inhibition of histone deacetylase activity.
Kang KA; Piao MJ; Kim KC; Zheng J; Yao CW; Cha JW; Kim HS; Kim DH; Bae SC; Hyun JW
Int J Oncol; 2013 Dec; 43(6):1907-14. PubMed ID: 24100442
[TBL] [Abstract][Full Text] [Related]
38. Cytoplasmic Localization of RUNX3 via Histone Deacetylase-Mediated SRC Expression in Oxidative-Stressed Colon Cancer Cells.
Kang KA; Piao MJ; Ryu YS; Maeng YH; Hyun JW
J Cell Physiol; 2017 Jul; 232(7):1914-1921. PubMed ID: 27990641
[TBL] [Abstract][Full Text] [Related]
39. Lack of preventive efficacy of FK228, a histone deacetylase inhibitor, against N-butyl-N-(4-hydroxybutyl) nitrosamine-induced urinary bladder carcinogenesis in p53+/- and p53+/+ mice.
Wei M; Wanibuchi H; Morimura K; Salim EI; Moku M; Doi K; Mitsuhashi M; Masuda C; Shen J; Kinoshita A; Fukushima S
Anticancer Res; 2004; 24(2B):785-90. PubMed ID: 15161027
[TBL] [Abstract][Full Text] [Related]
40. RUNX3 suppresses gastric epithelial cell growth by inducing p21(WAF1/Cip1) expression in cooperation with transforming growth factor {beta}-activated SMAD.
Chi XZ; Yang JO; Lee KY; Ito K; Sakakura C; Li QL; Kim HR; Cha EJ; Lee YH; Kaneda A; Ushijima T; Kim WJ; Ito Y; Bae SC
Mol Cell Biol; 2005 Sep; 25(18):8097-107. PubMed ID: 16135801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
